{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T19:21:08Z","timestamp":1772306468641,"version":"3.50.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.intimp.2020.107355","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T13:57:12Z","timestamp":1610459832000},"page":"107355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4"],"prefix":"10.1016","volume":"92","author":[{"given":"Mohammad Reza Mohammad Hoseini","family":"Azar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamed","family":"Aghazadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halgurd Nadhim","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi Rezai Seghin","family":"Sara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arezoo","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navid","family":"Shomali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rozita","family":"Tamjidifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Tarzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar Pashaei","family":"Sarand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faroogh","family":"Marofi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morteza","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaxi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siamak Sandoghchian","family":"Shotorbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2020.107355_b0005","doi-asserted-by":"crossref","first-page":"8775","DOI":"10.1002\/jcb.28164","article-title":"microRNA\u2010193a\u20105p inhibits migration of human HT\u201029 colon cancer cells via suppression of metastasis pathway","volume":"120","author":"Shirafkan","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"10","key":"10.1016\/j.intimp.2020.107355_b0010","doi-asserted-by":"crossref","first-page":"17081","DOI":"10.18632\/oncotarget.15059","article-title":"A panel of microRNA signature in serum for colorectal cancer diagnosis","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2020.107355_b0015","doi-asserted-by":"crossref","unstructured":"M. Jeffery, B.E. Hickey, P.N. Hider, Follow\u2010up strategies for patients treated for non\u2010metastatic colorectal cancer, Cochrane Database Syst. Rev. (9) (2019).","DOI":"10.1002\/14651858.CD002200.pub4"},{"issue":"15","key":"10.1016\/j.intimp.2020.107355_b0020","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2174\/0929867324666170111152436","article-title":"Colorectal cancer chemotherapy: the evolution of treatment and new approaches","volume":"24","author":"McQuade","year":"2017","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.intimp.2020.107355_b0025","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.3748\/wjg.v22.i5.1745","article-title":"Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances","volume":"22","author":"Lech","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"6824","key":"10.1016\/j.intimp.2020.107355_b0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","article-title":"Involvement of chemokine receptors in breast cancer metastasis","volume":"410","author":"M\u00fcller","year":"2001","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.intimp.2020.107355_b0035","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1200\/JCO.2005.07.078","article-title":"Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival","volume":"23","author":"Kim","year":"2005","journal-title":"JCO"},{"issue":"11","key":"10.1016\/j.intimp.2020.107355_b0040","first-page":"801","article-title":"The CXCL12 (SDF-1)\/CXCR4 chemokine axis: oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy","volume":"16","author":"Zhou","year":"2018","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.intimp.2020.107355_b0045","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.3389\/fimmu.2018.02159","article-title":"The role of CXC chemokine receptors 1\u20134 on immune cells in the tumor microenvironment","volume":"9","author":"Susek","year":"2018","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2020.107355_b0050","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1245\/s10434-009-0599-x","article-title":"Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1\/CXCR4 Axis","volume":"16","author":"Matsusue","year":"2009","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107355_b0055","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ijc.27670","article-title":"The role of CXCR3 and CXCR4 in colorectal cancer metastasis","volume":"132","author":"Murakami","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2020.107355_b0060","doi-asserted-by":"crossref","unstructured":"W.-S. Huang, M.-C. Hsieh, C.-Y. Huang, Y.-H. Kuo, S.-Y. Tung, C.-H. Shen, Y.-Y. Hsieh, C.-C. Teng, K.-F. Lee, T.-C. Chen, K.-C. Lee, H.-C. Kuo, The association of CXC receptor 4 mediated signaling pathway with oxaliplatin-resistant human colorectal cancer cells, PloS One 11(9) (2016) e0159927-e0159927.","DOI":"10.1371\/journal.pone.0159927"},{"issue":"12","key":"10.1016\/j.intimp.2020.107355_b0065","doi-asserted-by":"crossref","first-page":"22581","DOI":"10.1002\/jcp.28823","article-title":"The effect of combined miR\u2010200c replacement and cisplatin on apoptosis induction and inhibition of gastric cancer cell line migration","volume":"234","author":"Ghasabi","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.intimp.2020.107355_b0070","doi-asserted-by":"crossref","first-page":"9495","DOI":"10.1002\/jcb.28225","article-title":"Downregulation of miR\u2010146a promotes cell migration in Helicobacter pylori \u2013negative gastric cancer","volume":"120","author":"Shomali","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.intimp.2020.107355_b0075","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12029-019-00239-4","article-title":"Evaluation of the methylation of MIR129-2 gene in gastric cancer","volume":"51","author":"Alizadeh","year":"2020","journal-title":"J. Gastrointest. Canc."},{"key":"10.1016\/j.intimp.2020.107355_b0080","doi-asserted-by":"crossref","unstructured":"Q. Fan, X. Hu, H. Zhang, S. Wang, H. Zhang, C. You, C.-Y. Zhang, H. Liang, X. Chen, Y. Ba, MiR-193a-3p is an important tumour suppressor in lung cancer and directly targets KRAS, Cell. Physiol. Biochem. 44(4) (2017) 1311-1324.","DOI":"10.1159\/000485491"},{"issue":"17","key":"10.1016\/j.intimp.2020.107355_b0085","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.1158\/1078-0432.CCR-17-0171","article-title":"miR-193a-3p is a key tumor suppressor in ulcerative colitis\u2013associated colon cancer and promotes carcinogenesis through upregulation of IL17RD","volume":"23","author":"Pekow","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2020.107355_b0090","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.canlet.2014.11.002","article-title":"MiR-193a-3p promotes the multi-chemoresistance of bladder cancer by targeting the HOXC9 gene","volume":"357","author":"Lv","year":"2015","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.intimp.2020.107355_b0095","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/febs.14724","article-title":"PTP 1B markedly promotes breast cancer progression and is regulated by miR-193a-3p","volume":"286","author":"Yu","year":"2019","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.intimp.2020.107355_b0100","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-017-0649-3","article-title":"Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel","volume":"36","author":"Yang","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2020.107355_b0105","unstructured":"M. Khordadmehr, R. Shahbazi, B. Baradaran, S. Sadreddini, D. Shanehbandi, K. Hajiasgharzadeh, M. Firouzamandi, MiR-193a-5p replacement can alter metastasis gene expression in breast adenocarcinoma cells in vitro."},{"issue":"1","key":"10.1016\/j.intimp.2020.107355_b0110","article-title":"CXCL12\/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer","volume":"7","author":"Yu","year":"2017","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.intimp.2020.107355_b0115","first-page":"751","article-title":"The impact of thymidylate synthase and methylenetetrahydrofolate reductase genotypes on sensitivity to 5-fluorouracil treatment in colorectal cancer cells","volume":"55","author":"Naghibalhossaini","year":"2017","journal-title":"Acta Med. Iran"},{"key":"10.1016\/j.intimp.2020.107355_b0120","doi-asserted-by":"crossref","unstructured":"S. Noorolyai, E. Baghbani, L. Aghebati Maleki, A. Baghbanzadeh Kojabad, D. Shanehbansdi, V. Khaze Shahgoli, A. Mokhtarzadeh, B. Baradaran, Restoration of miR-193a-5p and miR-146 a-5p Expression Induces G1 Arrest in Colorectal Cancer through Targeting of MDM2\/p53, Adv. Pharm. Bull. 10(1) (2020) 130-134.","DOI":"10.15171\/apb.2020.017"},{"issue":"6","key":"10.1016\/j.intimp.2020.107355_b0125","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/CAD.0b013e3280200428","article-title":"Establishment and gene analysis of an oxaliplatin-resistant colon cancer cell line THC8307\/L-OHP","volume":"18","author":"Tang","year":"2007","journal-title":"Anticancer Drugs"},{"issue":"7","key":"10.1016\/j.intimp.2020.107355_b0130","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1158\/1078-0432.CCR-05-1853","article-title":"Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer","volume":"12","author":"Xi","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2020.107355_b0135","first-page":"121","article-title":"5-Fluorouracil and oxaliplatin modify the expression profiles of microRNAs in human colon cancer cells in vitro","volume":"23","author":"Zhou","year":"2010","journal-title":"Oncol. Rep."},{"issue":"22","key":"10.1016\/j.intimp.2020.107355_b0140","doi-asserted-by":"crossref","first-page":"7584","DOI":"10.1074\/jbc.RA120.013347","article-title":"Genome-wide single-nucleotide resolution of oxaliplatin\u2013DNA adduct repair in drug-sensitive and -resistant colorectal cancer cell lines","volume":"295","author":"Vaughn","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.intimp.2020.107355_b0145","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.2217\/fon.15.235","article-title":"Cellular signaling pathways implicated in metastasis of colorectal cancer and the associated targeted agents","volume":"11","author":"Liu","year":"2015","journal-title":"Future Oncol."},{"issue":"7043","key":"10.1016\/j.intimp.2020.107355_b0150","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.intimp.2020.107355_b0155","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1002\/jcp.27445","article-title":"The role of microRNAs regulating the expression of matrix metalloproteinases (MMPs) in breast cancer development, progression, and metastasis: JAVADIAN et al.","volume":"234","author":"Javadian","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2020.107355_b0160","doi-asserted-by":"crossref","unstructured":"W. Wang, X.-B. Shen, W. Jia, D.-B. Huang, Y. Wang, Y.-Y. Pan, The p53\/miR-193a\/EGFR feedback loop function as a driving force for non-small cell lung carcinoma tumorigenesis, Therapeutic Adv. Med. Oncol. 11 (2019) 1758835919850665.","DOI":"10.1177\/1758835919850665"},{"key":"10.1016\/j.intimp.2020.107355_b0165","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.biopha.2018.12.106","article-title":"Insights into the roles of miRNAs; miR-193 as one of small molecular silencer in osteosarcoma therapy","volume":"111","author":"Izadpanah","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.intimp.2020.107355_b0170","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s12672-014-0188-8","article-title":"Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193b","volume":"5","author":"Wahdan-Alaswad","year":"2014","journal-title":"HORM CANC"},{"key":"10.1016\/j.intimp.2020.107355_b0175","doi-asserted-by":"crossref","unstructured":"L. Lv, H. Deng, Y. Li, C. Zhang, X. Liu, Q. Liu, D. Zhang, L. Wang, Y. Pu, H. Zhang, The DNA methylation-regulated miR-193a-3p dictates the multi-chemoresistance of bladder cancer via repression of SRSF2\/PLAU\/HIC2 expression, Cell Death Disease 5(9) (2014) e1402-e1402.","DOI":"10.1038\/cddis.2014.367"},{"issue":"1","key":"10.1016\/j.intimp.2020.107355_b0180","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/1471-2407-13-280","article-title":"Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer","volume":"13","author":"Yong","year":"2013","journal-title":"BMC Cancer"},{"issue":"34","key":"10.1016\/j.intimp.2020.107355_b0185","doi-asserted-by":"crossref","first-page":"12241","DOI":"10.3748\/wjg.v20.i34.12241","article-title":"Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer","volume":"20","author":"Zhang","year":"2014","journal-title":"World J. Gastroenterol.: WJG"},{"issue":"4","key":"10.1016\/j.intimp.2020.107355_b0190","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1111\/jcmm.14121","article-title":"MiR\u2010139\u20105p, miR\u2010940 and miR\u2010193a\u20105p inhibit the growth of hepatocellular carcinoma by targeting SPOCK1","volume":"23","author":"Li","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"27","key":"10.1016\/j.intimp.2020.107355_b0195","doi-asserted-by":"crossref","first-page":"23480","DOI":"10.18632\/oncotarget.4346","article-title":"miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma","volume":"6","author":"Williams","year":"2015","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.intimp.2020.107355_b0200","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","article-title":"CXCL12 (SDF-1)\/CXCR4 pathway in cancer","volume":"16","author":"Teicher","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.intimp.2020.107355_b0205","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/onc.2015.139","article-title":"CXCL12\/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks","volume":"35","author":"Guo","year":"2016","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.intimp.2020.107355_b0210","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1159\/000367802","article-title":"Epithelial-mesenchymal transition and drug resistance: role, molecular mechanisms, and therapeutic strategies","volume":"37","author":"Sui","year":"2014","journal-title":"Oncol. Res. Treat"},{"issue":"8","key":"10.1016\/j.intimp.2020.107355_b0215","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/bjc.1998.617","article-title":"5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins","volume":"78","author":"Nita","year":"1998","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2020.107355_b0220","doi-asserted-by":"crossref","first-page":"C987","DOI":"10.1152\/ajpcell.00406.2006","article-title":"Stroma-derived factor (SDF-1\/CXCL12) and human tumor pathogenesis","volume":"292","author":"Kryczek","year":"2007","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"10.1016\/j.intimp.2020.107355_b0225","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/1471-2407-10-425","article-title":"LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells","volume":"10","author":"Shin","year":"2010","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.intimp.2020.107355_b0230","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1158\/1541-7786.MCR-05-0231","article-title":"Constitutively activated nuclear factor-kappaB, but not induced NF-kappaB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells","volume":"4","author":"Braeuer","year":"2006","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.intimp.2020.107355_b0235","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1423-0127-19-91","article-title":"CXC chemokine ligand 12\/stromal cell-derived factor-1 regulates cell adhesion in human colon cancer cells by induction of intercellular adhesion molecule-1","volume":"19","author":"Tung","year":"2012","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.intimp.2020.107355_b0240","doi-asserted-by":"crossref","unstructured":"M. Hemmatzadeh, H. Mohammadi, Snail-1 Silencing by siRNA Inhibits Migration of TE-8 Esophageal Cancer Cells Through Downregulation of Metastasis-Related Genes, 8(3) (2018) 437-445.","DOI":"10.15171\/apb.2018.051"},{"issue":"2","key":"10.1016\/j.intimp.2020.107355_b0245","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/onc.2012.37","article-title":"Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells","volume":"32","author":"Jung","year":"2013","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.intimp.2020.107355_b0250","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/jcp.22831","article-title":"Stromal cell-derived factor-1\/CXC receptor 4 and beta1 integrin interaction regulates urokinase-type plasminogen activator expression in human colorectal cancer cells","volume":"227","author":"Huang","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2020.107355_b0255","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1186\/s12885-015-1702-2","article-title":"Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26","volume":"15","author":"Cutler","year":"2015","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.intimp.2020.107355_b0260","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.7150\/jca.24474","article-title":"A Study on Effect of Oxaliplatin in MicroRNA Expression in Human Colon Cancer","volume":"9","author":"Evert","year":"2018","journal-title":"J. Cancer"},{"issue":"7","key":"10.1016\/j.intimp.2020.107355_b0265","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/jcp.22517","article-title":"5-fluorouracil drug alters the microrna expression profiles in MCF-7 breast cancer cells","volume":"226","author":"Shah","year":"2011","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.intimp.2020.107355_b0270","first-page":"1011","article-title":"Chemotherapy-induced modification of microRNA expression in esophageal cancer","volume":"26","author":"Hummel","year":"2011","journal-title":"Oncol. Rep."},{"issue":"11","key":"10.1016\/j.intimp.2020.107355_b0275","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1517\/13543780903292626","article-title":"Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth","volume":"18","author":"Wang","year":"2009","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"2","key":"10.1016\/j.intimp.2020.107355_b0280","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bbrc.2005.04.143","article-title":"Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2 signaling pathways","volume":"332","author":"Hwang","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1-2","key":"10.1016\/j.intimp.2020.107355_b0285","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11010-019-03598-5","article-title":"5-FU preferably induces apoptosis in BRAF V600E colorectal cancer cells via downregulation of Bcl-xL","volume":"461","author":"Shi","year":"2019","journal-title":"Mol. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.intimp.2020.107355_b0290","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.bbrc.2018.03.068","article-title":"Z-FL-COCHO, a cathepsin S inhibitor, enhances oxaliplatin-induced apoptosis through upregulation of Bim expression","volume":"498","author":"Seo","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2020.107355_b0295","doi-asserted-by":"crossref","unstructured":"H. Lee, C. Kim, H. Kang, H. Tak, S. Ahn, S.K. Yoon, H.-J. Kuh, W. Kim, E.K. Lee, microRNA-200a-3p increases 5-fluorouracil resistance by regulating dual specificity phosphatase 6 expression, Experimental & molecular medicine 49(5) (2017) e327-e327.","DOI":"10.1038\/emm.2017.33"},{"key":"10.1016\/j.intimp.2020.107355_b0300","doi-asserted-by":"crossref","unstructured":"L.Q. Li, D. Pan, Q. Chen, S.W. Zhang, D.Y. Xie, X.L. Zheng, H. Chen, Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition, Cell Physiol Biochem 47(4) (2018) 1533-1545.","DOI":"10.1159\/000490871"},{"issue":"1","key":"10.1016\/j.intimp.2020.107355_b0305","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-015-1702-2","article-title":"Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26","volume":"15","author":"Cutler","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.intimp.2020.107355_b0310","doi-asserted-by":"crossref","unstructured":"F. Jin, H. Ji, C. Jia, U. Brockmeier, D.M. Hermann, E. Metzen, Y. Zhu, B. Chi, Synergistic antitumor effects of endostar in combination with oxaliplatin via inhibition of HIF and CXCR4 in the colorectal cell line SW1116, PloS one 7(10) (2012) e47161-e47161.","DOI":"10.1371\/journal.pone.0047161"},{"issue":"8","key":"10.1016\/j.intimp.2020.107355_b0315","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1080\/15384101.2018.1464834","article-title":"LINC00152 promotes cell cycle progression in hepatocellular carcinoma via miR-193a\/b-3p\/CCND1 axis","volume":"17","author":"Ma","year":"2018","journal-title":"Cell Cycle"},{"key":"10.1016\/j.intimp.2020.107355_b0320","doi-asserted-by":"crossref","first-page":"5913195","DOI":"10.1155\/2017\/5913195","article-title":"Biological function of MicroRNA193a-3p in health and disease","volume":"2017","author":"Grossi","year":"2017","journal-title":"Int. J. Genomics"},{"issue":"26","key":"10.1016\/j.intimp.2020.107355_b0325","doi-asserted-by":"crossref","first-page":"39680","DOI":"10.18632\/oncotarget.9444","article-title":"MiR-193a-5p\/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma","volume":"7","author":"Lin","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2020.107355_b0330","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.12659\/MSM.894077","article-title":"Down-regulation of MiR-193a-3p dictates deterioration of HCC: a clinical real-time qRT-PCR study","volume":"21","author":"Liu","year":"2015","journal-title":"Med. Sci. Monitor: Int. Med. J. Exp. Clin. Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920338236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920338236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:28:23Z","timestamp":1761586103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920338236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":66,"alternative-id":["S1567576920338236"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107355","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107355"}}